Veterinary Orthopedics Market Expected To Propel Industry Growth By 2028: Grand View Research Inc.

 Veterinary Orthopedics Market Growth & Trends

The global veterinary orthopedics market size is anticipated to reach USD 930.1 million by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.3% from 2021 to 2028. The growing pet population, the prevalence of pet obesity and arthritis, which may require orthopedic surgery, are expected to drive the market. Moreover, increasing technological advancements in veterinary devices is another driver expected to contribute to the market growth.

According to the American Pet Products Association (APPA), about 84.9 million American homes (67% of U.S. households) owned a pet in 2019. This number is significantly greater than 2017 statistics wherein nearly 60.2 million U.S. households had at least one pet dog.

In 2019, Americans spent USD 95.7 billion on pets, which was USD 5.2 billion more than the expenditure in 2018. The rise in the number of pet owners and, subsequently, expenditure on pets, is boosting the animal health industry, including veterinary orthopedics. Owners are concerned about their pets and, hence, the demand for efficient treatment is rising. This trend is expected to continue, thus, fueling market growth during the forecast period.

According to Association for Pet Obesity Prevention (APOP), 56% of dogs and 60% of cats were overweight or obese in the U.S., in 2018. Obesity increases pressure on joints and bones. According to APPA, nearly 20.8 million dogs in the U.S. had undergone orthopedic surgeries in 2016. The most common orthopedic surgeries carried out on canines were femoral head osteotomy, bones fracture repair, cruciate ligament repair, and medial patellar luxation.

The prevalence of osteoarthritis in animals is increasing because of obesity, which is boosting demand for veterinary orthopedic devices and surgeries. According to Kingsbrook Animal Hospital, 20% of all dogs-regardless of age-in the U.S. had osteoarthritis in 2017.

The COVID-19 pandemic significantly impacted the market, as the number of elective surgeries went down due to lockdown and quarantine measures. However, the market is anticipated to be driven by the resumption of elective surgeries. In March 2020, the Harmony Veterinary Center in compliance with government guidelines, suspended all its elective procedures, surgeries, and dentistry services during the COVID-19 outbreak. However, this does not change the underlying need for these procedures and the market is expected to grow significantly as surgeries return to pre-COVID numbers.

Request a free sample copy or view report summary: Veterinary Orthopedics Market Report

Veterinary Orthopedics Market Report Highlights

• The growing pet population and ailments, combined with rising concern for zoonoses and pet expenditure, is anticipated to fuel market growth
• The implants segment accounted for the largest revenue share of the product segment in 2020. This can be attributed to an increase in the number of cases of severe musculoskeletal injuries or orthopedic disorders, such as cruciate ligament tears or hip and elbow dysplasia. This increases the need for surgery and, thus, the demand for implants
• The TTA segment held the largest revenue share in the application segment in 2020. Various factors driving the demand for this surgical method include increased ability to bear weight postsurgery, less pain, faster recovery, and fewer associated complications
• The veterinary hospitals and clinics segment dominated the end-use segment in 2020, as a wide range of procedures and treatment options are available in these healthcare settings
• In 2020, North America held a dominant revenue share in the market. This can be attributed to the local presence of key market players undertaking extensive strategic initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-orthopedics-market

Veterinary Orthopedics Market Segmentation

Grand View Research has segmented the global veterinary orthopedics market on the basis of product, application, end-use, and region:

Veterinary Orthopedics Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instrument
• Implants
  • Plates
    • Compression plates
    • Arthrodesis plates
    • Acetabulum plates
  • Screws
  • Others

Veterinary Orthopedics Application Outlook (Revenue, USD Million, 2016 - 2028)

• Total Knee Replacement
• Total Hip Replacement
• Total Elbow Replacement
• Trauma Fixation
• TPLO
• TTA
• Lateral Fixation
• Others

Veterinary Orthopedics End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Others

Veterinary Orthopedics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Veterinary Orthopedics Market

• Braun Melsungen AG
• Veterinary Orthopedic Implants
• Kyon AG
• STERIS
• Integra LifeSciences Corporation
• Ortho Max Manufacturing Company Pvt. Ltd.
• BioMedtrix, LLC
• Surgical Holdings Veterinary
• GerVetUSA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Go Beyond Chatbots with an Intelligent Virtual Assistant

 

Know More@ https://www.grandviewresearch.com/industry-analysis/intelligent-virtual-assistant-industry

The need for improved efficiency across service-based companies and the integration of Artificial Intelligence (AI) powered virtual assistants among various devices such as tablets, computers, and smartphones, among others, is anticipated to boost the market growth. An Intelligent Virtual Assistant (IVA) is capable of fulfilling a wide range of customer service roles such as ease to navigate, offer product information, assist customers in paying bills, and carry out transfers or complete forms, and direct problem queries to human agents in customer service. Such factors are prompting banking and financial institution across the world to integrate virtual assistants, leading to industry growth.

The Next In-Vehicle Experience: Automotive Digital Cockpit

 

Know More- https://www.grandviewresearch.com/industry-analysis/automotive-digital-cockpit-market

The Covid-19 pandemic has affected the overall automotive industry, leading to a subsequent decline in the growth of the market as a result of low automotive sales and new requirements. However, the increased adoption of in-vehicle telematics, infotainment system, safety and pollution sensors, navigation, and the internet of things is a prominent factor driving the demand for automotive digital cockpit solutions. Furthermore, the growing demand for improved comfort, safety, and convenience in vehicles, especially in emerging and developed economies, is anticipated to boost the growth of the market over the forecast period. The growing luxury and high-end car segment and rising use of autonomous vehicle technology are also likely to contribute to market growth.

Global L-carnitine Market Pegged For Strong Growth During 2021-2028: Grand View Research Inc.

 L-carnitine Market Growth & Trends

The global L-carnitine market size is expected to reach USD 276.0 million by 2028, expanding at a CAGR of 5.1%, as per a new report by Grand View Research Inc. Growing consumer awareness regarding product benefits, along with increasing demand from end-use industries such as pharmaceutical, nutraceutical, and animal feed, is projected to drive the market over the forecast period.

L-carnitine and its derivatives are used for numerous applications including male infertility, kidney treatment, cardiovascular diseases, weight reduction, and bone mass. It is also used in various products including animal feed, health supplements, functional drinks, medicines, and other nutraceutical products.

Manufacturers are focused on R&D activities to reduce the complexity in manufacturing techniques as well as product differentiation. Major manufacturers like Lonza, Ajinomoto, Sigma Tau Group, and Seikatsu have patented their manufacturing processes. Production of L-carnitine by chemical synthesis is executed on an industrial scale. However, manufacturers prefer bioprocess for the production, as the process generates higher yield and lesser waste as compared to chemical synthesis.

Companies engaged in the production and export of L-carnitine follow stringent standards such as current goods manufacturing procedure (CGMP), sanitary standard operation procedure (SSOP), and ISO standards. Companies offering food-grade products are required to obtain kosher and halal certifications.

In 2018, North America emerged as the largest regional market. The growth in this region can be attributed to increasing research and development activities in pharmaceutical and nutraceutical industries. Furthermore, increasing demand for pet supplements and animal feed formulations is expected to drive industry growth over the forecast period.

Request a free sample copy or view report summary: L-carnitine Market Report

L-carnitine Market Report Highlights

• Increasing preventive healthcare in major economies across the globe, including U.S., China, and India, has led to rising consumption of functional drinks, which in turn, is expected to propel product demand
• The market exhibits production of L-carnitine through biotechnological techniques using micro-organisms or enzymes. These processes use achiral precursors or racemic mixtures as raw materials for extraction of L-carnitine and offer the highest yield as compared to other means
• Increasing demand for animal feed from emerging economies such as China, India, and Vietnam are expected to drive the feed grade product segment over the forecast period
• Key L-Carnitine Market players include Lonza Group Ltd., Northeast Pharmaceutical Group Co., Ltd. (NEPG), Biosint S.p.A., Cayman Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Ceva Santé Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., Chengda Pharmaceuticals Co. Ltd., Huanggang Huayang Pharmaceutical Co. Ltd., and Hubei Yuancheng Technology Co. Ltd.
• Manufacturers in the market enter into contracts with suppliers and buyers, thereby gaining a competitive edge in the market. They have also been investing heavily in R&D and capacity expansions to increase their market share.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-l-carnitine-market

L-carnitine Market Segmentation

Grand View Research has segmented the global L-Carnitine market on the basis of process, product, application, and region:

L-carnitine Process Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• Chemical Synthesis
• Bioprocess

L-carnitine Product Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• Food & Pharma Grade
• Feed Grade

L-carnitine Application Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• Animal Feed
• Healthcare Products
• Functional Food & Beverages
• Medicines

L-carnitine Regional Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of L-carnitine Market

• Lonza
• Northeast Pharmaceutical Group Co., Ltd. (NEPG)
• Biosint S.p.A.
• Cayman Chemical
• Merck KGaA
• Tokyo Chemical Industry Co., Ltd.
• Ceva
• Kaiyuan Hengtai Nutrition Co., Ltd.
• ChengDa PharmaCeuticals Co., Ltd.
• Huanggang Huayang Pharmaceutical Co. Ltd.
• HuBeiYuancheng SaichuangTechnology Co, .Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surfing Apparel And Accessory Market Size Is Expected To Reach USD 1.82 Billion by 2028

 Surfing Apparel And Accessory Market Growth & Trends

The global surfing apparel and accessory market size is expected to reach USD 1.82 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.0% from 2021 to 2028. Surfing is gaining popularity among water adventurers as people could follow all the social distancing guidelines while surfing. Surfing clothes and accessories are also gaining popularity because surfing was one of the only sports that people could participate in during the pandemic.

In 2020, the surf apparel product segment held the largest market share, and this trend is likely to continue throughout the forecast period. The development of novel materials and technical textiles for the creation of fashionable and high-performance surfwear or apparel has aided market expansion. Furthermore, as the number of female surfers has increased, so does the demand for surfing-inspired clothing such as bikinis, swimsuits, shorts, t-shirts, short onesies, and vests made of water-resistant fabrics, such as polyester.

In the surf apparel industry, a recent trend has been the increase in the number of sustainable items. Consumers are choosing environmentally-friendly surf apparel that does not pollute the environment. The majority of surf clothing and accessory producers are based in Europe, Asia Pacific, and North America, where the necessary raw materials are readily available.

Since stand-alone shops were authorized to reopen in June, board-sports businesses have reported a surge in hard goods sales. On July 13, 2020, the state government issued a decree requiring stores in indoor malls in certain California counties to remain closed. According to Bob Abdel, co-owner and buyer of Huntington Beach, Calif.-based Jack's Surfboards, the business is good, the only issue is with the inventory. He stated that Surfboards, skateboards, and wetsuits are coveted commodities. Orders take five weeks to come to retailers and a lot of businesses were caught off guard. As a result, finding items has been quite difficult for consumers. Soft-goods sales have also been hampered by supply-chain problems. During the shutdown of non-essential industries, many surf apparel companies suspended manufacturing. There have also been issues with staffing industries and warehouses in the United States since some workers sought to avoid being exposed to COVID-19.

Channel Islands Surfboards, Quiksilver, Firewire Surfboards, and Billabong International Limited, among other prominent surf apparel manufacturers, have been concentrating on the production and design of innovative materials and technical fabrics for trendy and high-performance surfwear or apparel, which has positively impacted market growth.

Request a free sample copy or view report summary: Surfing Apparel And Accessory Market Report

Surfing Apparel And Accessory Market Report Highlights

• The surf apparel product segment accounted for the largest share of over 75.0% in 2020. This is attributed to professional surfers' increased desire for accessories, such as wetsuit booties and reef socks
• The online distribution channel segment is estimated to expand at the highest CAGR of 6.5% over the forecast period
• North America held the largest share of over 45.0% in 2020 owing to the growing popularity of surfing among adventure enthusiasts in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surfing-apparel-accessories-market

Surfing Apparel And Accessory Market Segmentation

Grand View Research has segmented the global surfing apparel and accessory market on the basis of product, distribution channel, and region:

Surfing Apparel & Accessory Product Outlook (Revenue, USD Million, 2016 - 2028)

• Surf Apparel
• Surf Accessories

Surfing Apparel & Accessory Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Offline
• Online

Surfing Apparel & Accessory Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • UK.
  • France
  • Spain
• Asia Pacific
  • Australia
  • New Zealand
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Surfing Apparel And Accessory Market

• Billabong
• Hurley, Inc.
• O’Neill
• RVCA
• Volcom, LLC
• GLOBE INTERNATIONAL LIMITED
• REEF
• Roxy, Inc.
• Ltd.
• Quiksilver, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biosimulation Market Size Is Anticipated To Reach USD 6.83 Billion by 2028

 Biosimulation Market Growth & Trends

The global biosimulation market size is anticipated to reach USD 6.83 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.9% from 2021 to 2028. The key factors fueling the market growth include the increasing incidence of chronic diseases, increase in healthcare digitization, and usage of biosimulation solutions in clinical trials and research.

The need for drug discovery and development amidst the prevalence of acute and chronic diseases has resulted in an increase in the allocation of funds for R&D activities, which has propelled the adoption of biosimulation solutions. In addition, a high drug attrition rate leads to an increase in the cost of clinical trials, which is expected to drive the clinical urgency to incorporate in silico biology approach. This approach significantly reduces the probability of drug failure by predicting biological interactions, thereby reducing the overall costs.

Arise in drug relapse rates, drug resistance cases, and limited availability of drugs to treat diseases such as AIDS have led to high clinical urgency for the adoption of biosimulation in applications, such as drug development and drug discovery.

The COVID-19 pandemic also had a significant impact on the market. Simulations Plus, for instance, launched the StrategiesPlus COVID-19 ACT Program in March 2020 for speeding consulting assistance to any organization involved in the COVID-19 research. As of November 2020, the company declared that its business was not materially adversely affected. However, the continuing spread of COVID-19 and the measures taken by the governments of the affected countries are likely to disrupt the supply chain and adversely impact its business and financial performance.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. Biosimulation solutions enable cost-effective prediction of toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse and adverse events at later stages.

Request a free sample copy or view report summary: Biosimulation Market Report

Biosimulation Market Report Highlights

• In terms of product, software dominated the market in 2020. This can be attributed to the availability of a wide range of application-specific software that suits research requirements. Furthermore, biosimulation software is being used in clinical trials and it also eases modeling and target drug identification
• By application, the drug development segment accounted for the largest share in 2020
• Based on end use, pharmaceutical and biotechnology companies dominated the market in 2020 due to increasing strategic initiatives
• North America grabbed the largest share in 2020. The presence of a favorable reimbursement framework (especially post the implementation of the Affordable Care Act) and sophisticated healthcare infrastructure is expected to drive the North American market over the forecast period
• Asia Pacific is expected to grow significantly during the forecast period owing to the increase in the number of CROs, growth in spending on healthcare IT, and rapidly evolving healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosimulation-market

Biosimulation Market Segmentation

Grand View Research has segmented the global biosimulation market on the basis of product, application, end use, and region:

Biosimulation Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services
  • In-house Services
  • Contract Services

Biosimulation Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Development
• Drug Discovery
• Others

Biosimulation End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

List of Key Players of Biosimulation Market

• Certara
• DassaultSystemes
• Advanced Chemistry Development
• Simulation Plus
• Schrodinger, Inc.
• Chemical Computing Group ULC
• PhysiomicsPlc
• Rosa & Co. LLC
• BioSimulation Consulting Inc.
• Genedata AG
• Instem Group of Companies
• PPD, Inc. (Evidera)
• Insilico Biotechnology AG
• Immunetrics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In-vitro Toxicology Testing Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 In-vitro Toxicology Testing Market Growth & Trends

The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.7% from 2021 to 2028. In recent times, the validation and acceptance of in-vitro and alternative testing methods by regulatory agencies are increasing at lucrative pace. Also, ongoing technological advancements to replace the use of animals for toxicology testing purposes have spurred the use of in vitro testing models, in turn, driving the market.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market. Several companies offer HTT-based in vitro toxicology analysis, e.g., Solidus Bioscience’s MetaChip Technology, which provides a solution for in vitro toxicology analysis using HTT.

Request a free sample copy or view report summary: In-vitro Toxicology Testing Market Report

In-vitro Toxicology Testing Market Report Highlights

• Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2020
• Omics technology is anticipated to register lucrative growth over the forecast period as RNA sequencing and shotgun proteomics are increasingly used in research settings
• The cosmetics industry is expected to be the fastest-growing segment in the near future, creating new avenues for the expansion of HTTs across the globe
• The cellular assays segment dominated the market in 2020 owing to advancements in cell-based technologies, including label-free detection and high-content screening
• The potential of cell imaging technologies is combined with high-content cell screening assays and high-throughput assays for the development of multi-parameter assays
• Systemic toxicology emerged as the leading application segment in 2020 as it plays a key role in risk assessment during drug development procedures
• For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
• The pharmaceutical industry segment dominated the market in 2020 as toxicological testing is a prerequisite step for drug development
• Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models
• In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period
• This is due to increasing initiatives by public agencies to encourage acceptance of non-animal test models
• The key participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products
• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market

In-vitro Toxicology Testing Market Segmentation

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region:

In-vitro Toxicology Testing End-use Outlook, (Revenue, USD Million, 2018 - 2028)

• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes and Research Laboratories
• Diagnostics
• Chemical Industry
• Food Industry

In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2018 - 2028)

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology

In-vitro Toxicology Testing Application Outlook, (Revenue, USD Million, 2018 - 2028)

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular Toxicity
• Others

In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2018 - 2028)

• Cellular Assay
  • Live Cells
    • High Throughput / High Content Screening
    • Molecular Imaging
      • Confocal Microscopy
      • Others
    • Others
  • Fixed Cells
• Biochemical Assay
• In-Silico
• Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East Africa (MEA)
  • South Africa

List of Key Players of In-vitro Toxicology Testing Market

• Merck KGaA
• Charles River
• Bio-Rad Laboratories, Inc.
• Abbott
• Thermo Fisher Scientific Inc.
• Catalent, Inc.
• GE Healthcare
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Evotec
• Creative Bioarray
• Gentronix
• BioIVT
• SGS SA
• Agilent Technologies.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Orthopedic Navigation Systems Market to Reach Around USD 6.05 Billion by 2028: Grand View Research Inc.

 Orthopedic Navigation Systems Market Growth & Trends

The global orthopedic navigation systems market size is expected to reach USD 6.05 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.4% from 2021 to 2028. The increasing geriatric population prone to orthopedic diseases is a key contributing factor propelling the demand for orthopedic navigation systems. Osteoarthritis and osteoporosis are the most common disorders in the population aged 70 years and above. The growing prevalence of these disorders results in an increased economic burden on many countries.

Due to the COVID-19 pandemic, non-emergency procedures were canceled or postponed, which adversely affected the global market as restrictions resulted in delays to a number of procedures. In the U.K., the number of individuals waiting for surgical procedures has increased to approximately 10 million from 4 million before the pandemic. While the U.S. is expected to have a backlog of more than 1 million joint and spinal surgeries by mid-2022. Currently, most nations have elevated restrictions on elective surgery. As a result of the recommencement of surgical procedures at full force, the market is anticipated to catch up the pace over the forecast years.

Rising awareness about the benefits of minimally invasive surgery is expected to further boost the product demand in the coming years. Some of the benefits include less blood loss, reduced risk of damage, condensed risk of infection and postoperative pain, and quicker recovery from surgery. In addition, the introduction of technologically advanced products is boosting market growth. For instance, in July 2021, SeaSpine Holdings Corp. broadcasted the FDA 510(k) authorization for its 7D Percutaneous Spine Module. This module is for minimally invasive surgery. This signifies a novel application and improved functionality for its 7D Flash Navigation System.

Request a free sample copy or view report summary: Orthopedic Navigation Systems Market Report

Orthopedic Navigation Systems Market Report Highlights

• The knee segment accounted for the largest revenue share in 2020 owing to the rising prevalence of osteoarthritis, which is the most common form of arthritis and the leading cause of chronic pain and physical disability in elder persons
• The spine segment is anticipated to witness the fastest CAGR from 2021 to 2028 due to the rising incidence of spinal deformities
• According to a CDC report, in 2019, around 34.0% of the adult population and 62.0% of the elderly population were affected by spinal deformities
• The optical navigation system segment held the largest revenue share in 2020 owing to the affordability of the technology as compared to other navigation systems
• The hospitals segment held the largest revenue share in 2020. Hospitals use technologically advanced medical devices to improve the Point-of-Care (PoC), which drives segment growth
• North America dominated the global market in 2020 due to the availability of better-quality healthcare infrastructure and favorable government initiatives
• The market is highly competitive as major players are focusing more on the product innovation strategies due to changing needs of healthcare establishments, surgeons, and patients
• The market is moving toward consolidation as large companies are focused on strategic acquisitions of smaller companies to gain a competitive advantage

Access Press Release@ https://www.grandviewresearch.com/press-release/global-orthopedic-navigation-systems-market

Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the global orthopedic navigation systems market on the basis of application, technology, end-use, and region:

Orthopedic Navigation Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

• Knee
• Hip
• Spine

Orthopedic Navigation Systems Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Electromagnetic
• Optical
• Others

Orthopedic Navigation Systems End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Orthopedic Navigation Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Switzerland
  • Italy
  • Spain
  • Belgium
  • Austria
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

List of Key Players of Orthopedic Navigation Systems Market

• Braun Melsungen AG
• Stryker
• Medtronic
• Smith+Nephew
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Zimmer Biomet
• Amplitude Surgical
• Kinamed, Inc.
• Globus Medical
• OrthAlign

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐒𝐢𝐠𝐧𝐚𝐠𝐞 - 𝐓𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐀𝐧𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

 

Know More- https://www.grandviewresearch.com/industry-analysis/digital-signage-market

Rising demand for advanced products that require digitized information management and guidance and can be accessed from remote locations. This is also among the key factors anticipated to boost the global market growth during the forecast period. With digitized display technology, information is provided in a digitized format that includes motion and pictures to promote a business more effectively than the traditional modes of reaching out to customers. Moreover, the integration of biometric technology with modern digitized signs has developed products, such as track heat paths and gaze tracking. 

𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐁𝐢𝐠 𝐓𝐡𝐢𝐧𝐠

Know More@ https://www.grandviewresearch.com/industry-analysis/chatbot-market

A chatbot is an interactive application developed using either a set of rules or artificial intelligence technology. It is designed to interact with humans through the textual conversation process and is integrated with various messaging services, thereby assisting users in various sectors. Various innovations carried out in Artificial Intelligence (AI), and Machine Learning (ML) technologies are expected to enhance the features of chatbots, which, in turn, would drive demand.

 

Pulse Oximeter Market to Record an Exponential CAGR by 2028: Grand View Research Inc.

 Pulse Oximeter Market Growth & Trends

The global pulse oximeter market size is expected to reach USD 3.4 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Technological advancements in products, growing healthcare costs, and readmission, and increasing adoption of pulse oximetry devices are expected to boost market growth during the forecast period. Market players are introducing devices that are more efficient and support telehealth approaches. For instance, in February 2017, the company received a CE mark for Rad-97 Pulse CO-Oximeter used to monitor blood pressure at set intervals. It is also capable of transferring the data to a remotely connected device.

There are various other types of oximeters such as wrist-worn oximeters, bedside, or desktop oximeters, and mobile phone pulse oximeters, the latest addition. These oximetry devices are equipped with a sensor that is compatible with the software installed in a user’s mobile phone, which analyzes data to display information. For instance, iHealth Labs, a subsidiary of a China-based company, Andon Health, offers such products. In October 2013, the company received FDA approval for its wireless pulse oximetry device.

Request a free sample copy or view report summary: Pulse Oximeter Market Report

Pulse Oximeter Market Report Highlights

• The fingertip pulse oximetry devices are being used by customers to self-monitor symptoms of COVID-19 contributing to segment growth since the onset of the pandemic
• In handheld pulse oximetry devices, the probe, which is very delicate and prone to damage, can be replaced, unlike in fingertip oximeters, and is expected to be in high demand due to the advantage of reduced risk of COVID-19 transmission
• There is an upward trend in the use of the medical device in homecare settings as it enables tracking and storing of patient's oxygen level readings, which reduces the need for hospital readmissions
• North America held the largest share in the market in 2020 due to factors such as availability of funds for R&D. The sales for fingertip pulse oximetry devices soared in January 2020 and March 2020 in the U.S. post the country-wide spread of the novel coronavirus and release of the WHO guidelines citing the oximeter as an essential device for monitoring blood oxygen during self-management
• In Asia Pacific, the demand for medical devices has increased from hospitals for monitoring critically ill COVID-19 patients. As the spread of the novel coronavirus has progressed significantly, the Ministry of Health and Family Welfare in India has notified all healthcare facilities to make necessary arrangements for devices used in diagnostics, treatment, and management of Severe Acute Respiratory Syndrome (SARS)
• The industry is also witnessing mergers, acquisitions, and licensing agreements. For instance, in December 2016, Nihon Kohden announced an absorption-type merger of 11 wholly-owned consolidated subsidiaries to improve management and efficiency of operations

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pulse-oximeters-market

Pulse Oximeter Market Segmentation

Grand View Research has segmented the global pulse oximeter market on the basis of type, end-use, and region:

Pulse Oximeters Type Outlook(Revenue, USD Million, 2016 - 2028)

• Fingertip
• Handheld
• Others

Pulse Oximeters End-use Outlook(Revenue, USD Million, 2016 - 2028)

• Hospitals & Other Healthcare Facilities
• Homecare

Pulse Oximeters Regional Outlook(Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Pulse Oximeters Market

• Medtronic (Covidien)
• Carefusion Corp.
• GE Healthcare
• Philips Healthcare
• Masimo
• CAS Medical Systems, Inc.
• Opto Circuits India Ltd.
• Nonin Medical, Inc.
• Smiths Medical
• Welch Allyn
• Spacelabs Healthcare
• Meditech Equipment Co.
• Nihon Kohden Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Diabetes Devices Market Forecast 2028 Top Companies, Trends and Growth Factors Details for Business Development

 Diabetes Devices Market Growth & Trends

The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Request a free sample copy or view report summary: Diabetes Devices Market Report

Diabetes Devices Market Report Highlights

• North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches
• By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate
• In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage
• In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements
• In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage
• In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices
• By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies
• By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment
• The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diabetes-devices-market

Diabetes Devices Market Segmentation

Grand View Research has segmented global diabetes devices market on the basis of type, distribution channel, end-use, and region:

Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• BGM Devices
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Homecare
• Diagnostic Centers

Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Czech Republic
  • Poland
  • Switzerland
  • Turkey
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Oman

List of Key Players of Diabetes Devices Market

• Medtronic plc
• Abbott Laboratories
• Hoffmann-La-Ltd.
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Ypsomed Holdings
• Companion Medical
• Sanofi
• Valeritas Holding Inc.
• Novo Nordisk
• Arkray, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Craniomaxillofacial Devices Market Expected To Propel Industry Growth At CAGR of 9.0% Through 2028: Grand View Research Inc.

 

Craniomaxillofacial Devices Market Growth & Trends

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growingpreferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Request a free sample copy or view report summary: Craniomaxillofacial Devices Market Report

Craniomaxillofacial Devices Market Report Highlights

• In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
• The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
• Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
• Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cmf-devices-market

Craniomaxillofacial Devices Market Segmentation

Grand View Research has segmented the global craniomaxillofacial devices market on the basis of product, material, application, and region:

CMF Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Cranial Flap Fixation
• CMF Distraction
• Temporomandibular Joint Replacement
• Thoracic Fixation
• Bone Graft Substitute
• CMF Plate & Screw Fixation

CMF Devices Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Bioabsorbable Material
• Ceramics

CMF Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Neurosurgery & ENT
• Orthognathic & Dental Surgery
• Plastic Surgery

CMF Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Craniomaxillofacial Devices Market

• DePuy Synthes (J&J)
• Stryker Corp.
• Medtronic plc
• Zimmer Biomet

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.